English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  50687368    線上人數 :  248
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"jyh ming liou"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 66-90 / 184 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-05-27T08:20:52Z Mass eradication of helicobacter pylori to prevent gastric cancer: Theoretical and practical considerations Lee Y.-C.; Chiang T.-H.; JYH-MING LIOU; Chen H.-H.; Wu M.-S.; Graham D.Y.
臺大學術典藏 2021-05-27T08:20:52Z Statins and the risk of pancreatic cancer in Type 2 diabetic patients - A population-based cohort study Chen M.-J.; Tsan Y.-T.; JYH-MING LIOU; Lee Y.-C.; Wu M.-S.; Chiu H.-M.; Wang H.-P.; Chen P.-C.
臺大學術典藏 2021-05-27T08:20:52Z Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease Tseng P.-H.; Yang W.-S.; JYH-MING LIOU; Lee Y.-C.; Wang H.-P.; Lin J.-T.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:51Z Massive left pleural effusion after endoscopic variceal therapy Wu W.-K.; Wang H.-P.; JYH-MING LIOU; Wu M.-S.; Chen Y.-T.
臺大學術典藏 2021-05-27T08:20:51Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial JYH-MING LIOU; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:51Z Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection Chen M.-J.; JYH-MING LIOU; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:51Z Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects JYH-MING LIOU; Lin J.-T.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:50Z Reply to Kim J.S. and Kim B.-W. JYH-MING LIOU; Chang C.-Y.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:50Z Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection Chen P.-Y.; Wu M.-S.; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; JYH-MING LIOU; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-05-27T08:20:50Z letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? Authors' reply JYH-MING LIOU; Chen M.-J.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:49Z Treatment of Helicobacter pylori infection: Where are we now? JYH-MING LIOU; Wu M.-S.; Lin J.-T.
臺大學術典藏 2021-05-27T08:20:49Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial JYH-MING LIOU; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-05-27T08:20:49Z Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice? JYH-MING LIOU; Lin J.-T.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:49Z Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial JYH-MING LIOU; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-05-27T08:20:48Z Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer Tsai K.-F.; JYH-MING LIOU; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S.
臺大學術典藏 2021-05-27T08:20:48Z The Impact of Gastric Atrophy on the Incidence of Diabetes Yu T.-Y.; Wei J.-N.; Kuo C.-H.; JYH-MING LIOU; Lin M.-S.; Shih S.-R.; Hua C.-H.; Hsein Y.-C.; Hsu Y.-W.; Chuang L.-M.; Lee M.-K.; Hsiao C.-H.; Wu M.-S.; Li H.-Y.
臺大學術典藏 2021-05-27T08:20:48Z Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; JYH-MING LIOU; Wu M.-S.; Hsu P.-N.; Cheng A.-L.
臺大學術典藏 2021-05-27T08:20:47Z Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials Chen M.-J.; Wu M.-S.; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; JYH-MING LIOU; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-05-27T08:20:47Z Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis Kuo Y.-T.; JYH-MING LIOU; El-Omar E.M.; Wu J.-Y.; Leow A.H.R.; Goh K.L.; Das R.; Lu H.; Lin J.-T.; Tu Y.-K.; Yamaoka Y.; Wu M.-S.; for the, Asian Pacific Alliance on Helicobacter; Microbiota
臺大學術典藏 2021-05-27T08:20:47Z Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale Sheu B.-S.; Wu M.-S.; Chiu C.-T.; Lo J.-C.; Wu D.-C.; JYH-MING LIOU; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.
臺大學術典藏 2021-05-27T08:20:47Z letter: levofloxacin resistance – a challenge for treatment of Helicobacter pylori infection. Authors' reply Chen P.-Y.; Wu M.-S.; JYH-MING LIOU
臺大學術典藏 2021-05-27T08:20:46Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H.; Yang H.-C.; Tseng T.-C.; JYH-MING LIOU; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-05-27T08:20:46Z First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; Wu M.-S.; JYH-MING LIOU; Wu C.-Y.
臺大學術典藏 2021-05-27T08:20:46Z First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; JYH-MING LIOU; Wang H.-P.; Chen L.-T.; Cheng A.-L.
臺大學術典藏 2021-05-27T08:20:45Z Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection JYH-MING LIOU; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; JYH-MING LIOU; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium

顯示項目 66-90 / 184 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目